The original "exercise in a pill" — and the register's best doping-scandal story. This entry closes the exercise-mimetic triad and carries genuine intrigue. Three threads: (1) it's the compound behind the famous "44% more endurance in sedentary mice" headline that coined "exercise mimetic"; (2) that
AICAR (Acadesine) is a small-molecule AMPK activator — not a peptide — and the original "exercise in a pill." By entering cells and mimicking AMP (as ZMP), it switches on AMPK, the master energy sensor, triggering a metabolic shift toward fat oxidation, insulin-independent glucose uptake, mitochondrial biogenesis (PGC-1α) and autophagy. Its fame comes from Narkar et al. (Cell, 2008): sedentary mice given AICAR for 4 weeks ran ~44% longer with no training — the study that coined "exercise mimetic." That headline launched a genuine doping saga: WADA banned it in 2009, French authorities suspected it at the Tour de France, and a supply-network bust followed in 2012 — with the striking irony that the discoverer of its performance effect (Ronald Evans) also created the anti-doping test for it. Meanwhile it lived a double life as a legitimate cardiac-surgery drug candidate and the lab's #1 AMPK research tool — until a 2021 review showed many of its effects are AMPK-independent, complicating decades of interpretation. The honest bottom line: elegant, historically important biology; zero human endurance data; a banned, detectable substance in sport; and a mechanism messier than its "clean AMPK activator" reputation.
not an approved consumer drug; Acadesine did not reach general approval. Investigational / research chemical. Not a cosmetic.
An honest grade per outcome — drawn from the evidence, not any catalogue. Hype and undemonstrated marketing claims grade low.
A credentialed reviewer (PharmD / PhD / MD) will be named before this entry is finalised. Until then, treat it as a working draft. Last updated July 2026 (status: foundational animal data, no human endurance trials, WADA-banned; watch AMPK-activator drug development — e.g. next-gen activators like O304 — rather than AICAR itself).
Grades reflect the published evidence, not our interest. No dosing, reconstitution, or administration is published for research compounds — that restraint is deliberate.
A neutral reference and a lawful-lane shop. Registered in Spain. Information for those who seek it — never promotion.
This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia SL — Registered in Spain.